tiprankstipranks
Viridian Therapeutics (GB:0K1R)
LSE:0K1R

Viridian Therapeutics (0K1R) Stock Investors

0 Followers
Based on 729,232 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0K1R
On average, investors allocate 2.96% of their portfolios to GB:0K1R
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0K1R

1.4%
Last 7
Days
3.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0K1R, out of 729,232 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0K1R Investor Activity

No data currently available
Based on the activity of 13,699 investors who made their portfolios public
The table shows changes in 0K1R in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0K1R Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
GE Aerospace
5.50%
+1.58%
+6.13%
161.87B
Industrials
Coherus Biosciences
2.64%
-1.40%
-8.48%
234.94M
Healthcare
Riot Platforms
4.96%
-0.82%
-0.97%
2.31B
Financial
Block
4.47%
-1.21%
-7.51%
43.36B
Technology
Micron
5.67%
+0.11%
+12.41%
118.23B
Technology
Plug Power
4.91%
-1.07%
-6.60%
1.76B
Industrials
Marathon Digital Holdings
5.51%
-0.69%
-3.33%
4.66B
Financial
ChargePoint Holdings
3.89%
-1.27%
-7.40%
575.77M
Consumer Cyclical
Trade Desk
4.68%
-1.69%
-4.45%
37.79B
Technology
Merck & Company
4.14%
-0.42%
-1.47%
318.56B
Healthcare
Based on the activity of 729,232 active portfolios
Open your Smart Portfolio

0K1R Investor Analysis

GB:0K1R investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
3.1%
of GB:0K1R holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GB:0K1R investors between 35–55

Between 35–55

9.0%
Last 30 days
Holdings Change
57.4%
of GB:0K1R holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GB:0K1R investors over 55

Over 55

7.1%
Last 30 days
Holdings Change
39.5%
of GB:0K1R holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GB:0K1R stock investors
See who invests in 0K1R according to age group and performance.

FAQ

How many retail Investors hold GB:0K1R?
<0.1% of TipRanks' retail investors hold GB:0K1R in their portfolios.
    What is GB:0K1R Investor Sentiment?
    GB:0K1R’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0K1R in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of GB:0K1R in the last 7 days.
        What percentage of retail investors changed their holding of GB:0K1R in the last 30 days?
        ▼ 3.9% of TipRanks' retail investors changed their holding of GB:0K1R in the last 30 days.
          What is the average age of retail investors who hold GB:0K1R?
          The average age of GB:0K1R Holders is between 35–55.
            What other stocks have GB:0K1R investors also bought?
            GB:0K1R Investors also bought GE, CHRS, RIOT, SQ, MU, PLUG, MARA, CHPT, TTD, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis